Report updated May 20, 2026
Sweet Dreams – Sugar Tracker
For families and individuals managing diabetes who use continuous glucose monitors and require real-time, multi-user status updates.
Sweet Dreams – Sugar Tracker is an established medical app that is available. With a 4.7/5 rating from 599 reviews, it shows polarized user reception.
What is Sweet Dreams – Sugar Tracker?
Sweet Dreams is a glucose monitoring app for families using continuous glucose monitors, available on iOS.
Families hire the app to coordinate glucose status updates and alerts, reducing the social and logistical friction of managing diabetes for loved ones.
Current Momentum
v1.31 · 1w ago
Maintenance- Integrated Twiist device support.
- Added mmol/L unit conversion.
- Released Spring Live Activity theme.
Active Nemesis
mySugr - Diabetes Tracker Log
By mySugr
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Displays real-time sugar levels on the lock screen without requiring device unlock
Shows sugar level data at the top of the screen while using other applications
Enables two-click pings and acknowledgements between family members
How much does it cost?
- Free tier
- Family subscription
Subscription model targets family units with a single-payment structure to lower individual barrier to entry.
Who Built It?
Marwan Elwaraki
Developing specialized medical utilities and privacy-focused tools to simplify health monitoring and personal organization for families.
Portfolio
3
Apps
Who is Marwan Elwaraki?
Marwan Elwaraki has pivoted from general productivity tools toward a high-utility niche in the medical category, specifically targeting the diabetes management ecosystem. By positioning the flagship app as a central hub for disparate Continuous Glucose Monitor (CGM) data, the publisher builds a functional moat based on hardware integration and real-time system features. The strategic focus on family-sharing subscription models suggests a move toward high-retention, utility-driven revenue rather than broad-market reach.
Who is Marwan Elwaraki for?
- Caregivers
- Families managing chronic health conditions who require real-time
- Collaborative data synchronization
Portfolio momentum
Maintained an active development cycle with 2 releases in the last 6 months, primarily supporting the flagship medical title.
What other apps does Marwan Elwaraki make?
What do users think recently?
Analysis in progress, available soon
What is the competitive landscape for Sweet Dreams – Sugar Tracker?
How's The Medical Market?
How does it evolve in the Medical market?
Sweet Dreams maintains a presence in the Medical category, ranking #22 Grossing in the UK and #57 Grossing in the US. The gap between its niche hardware utility and the broader category leaders signals a need for deeper clinical integration to scale.
| Country | Category | Chart | Rank | Change |
|---|---|---|---|---|
| 🇦🇷 Argentina | Medical | iOSGrossing | #12 | ▲23 |
| 🇬🇹 Guatemala | Medical | iOSGrossing | #19 | ▼7 |
The rivals identified
The Nemesis
mySugr - Diabetes Tracker Log
★4.5 (134.1K)mySugr GmbH
⚡Dominates the diabetes tracking niche with a massive user base and a high-frequency release cadence that keeps it ahead of feature parity.
Head to Head
The target app must leverage its superior niche hardware compatibility to capture power users while defending against mySugr's massive community-driven data moat.
What sets Sweet Dreams – Sugar Tracker apart
Focuses on a streamlined, family-oriented interface that simplifies complex diabetes management for non-technical caregivers.
Provides specialized support for a wider array of niche continuous glucose monitoring systems like Twiist and Medtrum.
What's mySugr - Diabetes Tracker Log's Edge
Maintains a massive, established community-driven data set that powers superior trend analysis and predictive insights.
Ships frequent updates with 12 releases in six months, ensuring rapid adaptation to new OS capabilities.
Contenders
Provides native, manufacturer-backed data accuracy and direct sensor communication that third-party trackers cannot fully replicate.
Serves as the primary gateway for clinical data management, creating a high barrier to entry for independent apps.
Features a long-established history of glucose-specific tracking that builds significant trust with long-term chronic condition patients.
Optimized for simple, manual entry workflows that appeal to users who prefer quick logging over complex automation.
OneTouch Reveal® app
★4.8 (158K)LifeScan, Inc.
📈A major manufacturer-backed app that competes for the same audience by bundling hardware connectivity with clinical insights.
Integrates directly with OneTouch hardware to provide seamless, error-free data synchronization for patients and their doctors.
Focuses on clinical-grade visualization of blood sugar patterns to help users identify trends in their daily health.
Peers
Provides complex medication scheduling and refill reminders that complement the target app's glucose tracking functionality.
Offers a robust notification engine designed to prevent missed doses, a critical pain point for diabetic patients.
Kardia
★4.8 (210.9K)AliveCor, Inc.
⚡Adjacent medical hardware app that demonstrates the high-value potential of integrating specialized diagnostic devices into mobile workflows.
Delivers medical-grade ECG analysis directly to the user's smartphone, setting a high bar for diagnostic app utility.
Maintains a strong regulatory-backed position that provides users with high confidence in the app's diagnostic accuracy.
New Kids on the Block
Zocdoc - Find and book doctors
★4.9 (156K)Zocdoc Inc
⚡High-velocity development with 26 releases in six months, indicating an aggressive push to capture the broader medical services market.
Aggressively integrates real-time appointment booking and provider discovery to solve the 'find-a-doctor' friction point.
Uses a high-frequency update cycle to rapidly iterate on user interface improvements and booking flow efficiency.
Spruce: Medical Communication
★4.9 (88K)Spruce Health
⚡Emerging threat focusing on the communication gap between patients and providers, a critical area for chronic disease management.
Provides a secure, HIPAA-compliant messaging platform that bridges the communication gap between patients and their care teams.
Focuses on asynchronous care delivery, allowing users to manage health concerns without requiring immediate in-person visits.
The outtake for Sweet Dreams – Sugar Tracker
Strengths to defend, gaps to attack
Core Strengths
- Family-subscription model lowers individual cost-per-user
- Lock-screen widgets create high-utility daily touchpoints
Critical Frictions
- Maintenance-mode update cadence
- Lack of professional-grade reporting tools
Growth Levers
- Expansion into clinical-grade data exports for doctors
- Integration with wearable health platforms
Market Threats
- Manufacturer-backed apps controlling sensor data pipeline
- High-velocity entrants capturing medical services funnel
What are the next best moves?
Ship professional-grade data exports because competitors offer clinical reporting → increase provider-referred user acquisition
Competitor analysis shows mySugr and OneTouch Reveal capture users via clinical-grade reporting tools.
Trade-off: Pause the Spring-themed UI update sprint — professional utility has higher retention impact than seasonal aesthetics.
Audit sensor integration roadmap because manufacturer-backed apps threaten the data pipeline → defend against platform-level churn
Libre and OneTouch Reveal leverage direct hardware control to create high barriers to entry.
Trade-off: Deprioritize the Message Group UI polish — sensor compatibility is a survival requirement.
A counter-intuitive read
The app's niche hardware compatibility is a stronger B2B distribution moat than its consumer-facing UI, as it captures families locked into specific, less-supported CGM sensors.
Feature Gaps vs Competitors
- Professional-grade reporting tools (available in mySugr but absent here)
- Automated clinical data syncing (available in OneTouch Reveal but absent here)
Key Takeaways
Sweet Dreams wins on family-centric coordination, but its lack of clinical-grade reporting leaves it vulnerable to manufacturer-backed rivals, so the PM must prioritize professional data exports to secure long-term retention.
Where Is It Heading?
Mixed Signals
The diabetes tracking market is consolidating around apps that provide clinical-grade insights rather than just passive logging. Sweet Dreams is currently advantaged by its family-coordination features, but it must pivot toward professional reporting to avoid being squeezed out by manufacturer-backed apps.
The maintenance-mode update cadence leaves the app vulnerable to competitors who rapidly integrate new sensor protocols, which erodes the competitive advantage of niche hardware support.
The family-subscription model effectively bundles users, which increases the lifetime value of the household segment and creates a barrier to switching for coordinated care groups.